First Clinical Isolation of an Azole-Resistant Aspergillus fumigatus Isolate Harboring a TR46 Y121F T289A Mutation in South America (original) (raw)

Aspergillus fumigatus Clinical Isolates Carrying CYP51A with TR34/L98H/S297T/F495I Substitutions Detected after Four-Year Retrospective Azole Resistance Screening in Brazil

Luiza Moretti

Antimicrobial Agents and Chemotherapy, 2019

View PDFchevron_right

Molecular Epidemiology of Aspergillus fumigatus Isolates Harboring the TR34/L98H Azole Resistance Mechanism

Emilio Bouza

Journal of Clinical Microbiology, 2012

View PDFchevron_right

Environmental study of azole-resistant Aspergillus fumigatus with TR 34 /L98H mutations in the cyp51 A gene in Iran

Bita Mousavi, Afsane Vaezi

Mycoses, 2013

View PDFchevron_right

First Determination of Azole Resistance in Aspergillus fumigatus Strains Carrying the TR34/L98H Mutations in Turkey

Harun Ağca, Beyza Ener, Berrin Tunca

Journal of Infection and Chemotherapy, 2015

View PDFchevron_right

A Cyp51B Mutation Contributes to Azole Resistance in Aspergillus fumigatus

Emilia Mellado

Journal of Fungi

View PDFchevron_right

First isolation of the pan-azole-resistant Aspergillus fumigatus cyp51A TR46/Y121F/T289A mutant in a UK patient

Rikesh Masania

International journal of antimicrobial agents, 2017

View PDFchevron_right

First azole‐resistant Aspergillus fumigatus isolates with the environmental TR 46 /Y121F/T289A mutation in Iran

Fatemeh Ahangarkani

Mycoses

View PDFchevron_right

First description of azole-resistant Aspergillus fumigatus due to TR 46 /Y121F/T289A mutation in France

Florent Morio

Antimicrobial Agents and Chemotherapy, 2015

View PDFchevron_right

Azole Resistance of Environmental and Clinical Aspergillus fumigatus Isolates from Switzerland

Jacques Schrenzel

Antimicrobial agents and chemotherapy, 2018

View PDFchevron_right

First Detection of TR34/L98H and TR46/Y121F/T289A Cyp51 Mutations in Aspergillus fumigatus isolates in the United States

Mohammad Albataineh

Journal of Clinical Microbiology, 2015

View PDFchevron_right

Interrogation of Related Clinical Pan-Azole-Resistant Aspergillus fumigatus Strains: G138C, Y431C, and G434C Single Nucleotide Polymorphisms in cyp51A, Upregulation of cyp51A, and Integration and Activation of Transposon Atf1 in the cyp51A Promoter

Dominique Sanglard

Antimicrobial Agents and Chemotherapy, 2011

View PDFchevron_right

Prospective evaluation of azole resistance in Aspergillus fumigatus clinical isolates in France

F. Botterel

View PDFchevron_right

cyp51A-Based Mechanisms of Aspergillus fumigatus Azole Drug Resistance Present in Clinical Samples from Germany

Martin Kuhns

Antimicrobial agents and chemotherapy, 2013

View PDFchevron_right

Surveillance for azole resistance in clinical and environmental isolates of Aspergillus fumigatus in Australia and cyp51A homology modelling of azole-resistant isolates

Sharon Chen

The Journal of antimicrobial chemotherapy, 2018

View PDFchevron_right

Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009

David Denning

Journal of Antimicrobial Chemotherapy, 2010

View PDFchevron_right

Epidemiological and Genomic Landscape of Azole Resistance Mechanisms in Aspergillus Fungi

Katsuhiko Kamei

Frontiers in Microbiology, 2016

View PDFchevron_right

Frequency and Evolution of Azole Resistance in Aspergillus fumigatus Associated with Treatment Failure1

David Perlin

Emerging Infectious Diseases, 2009

View PDFchevron_right

A novel Y319H mutation in CYP51C associated with azole resistance in Aspergillus flavus

Shivaprakash M R

Antimicrobial agents and chemotherapy, 2015

View PDFchevron_right

Interrogation of related Clinical Pan-azole Resistant Aspergillus fumigatus strains - G138C, Y431C and G434C SNPs in cyp51A, Upregulation of cyp51A and Integration and Activation of Transposon Atf1 into cyp51A Promoter

Dominique Sanglard

Antimicrobial Agents and Chemotherapy 2011, 2011

View PDFchevron_right

Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism

János Varga

PLOS Medicine, 2008

View PDFchevron_right

Is Azole Resistance in Aspergillus fumigatus a Problem in Spain?

Emilio Bouza

Antimicrobial Agents and Chemotherapy, 2013

View PDFchevron_right

Azole Resistance in Aspergillus fumigatus Isolates

Bita Mousavi, Afsane Vaezi

View PDFchevron_right

Azole resistant Aspergillus fumigatus in Denmark: a laboratory based study on resistance mechanisms and genotypes

Karen Astvad

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2016

View PDFchevron_right

Triazole-resistant Aspergillus fumigatus harbouring G54 mutation: Is it de novo or environmentally acquired?

Ruxandra Moroti

Journal of Global Antimicrobial Resistance, 2015

View PDFchevron_right

Hospital Environment as a Source of Azole-Resistant Aspergillus fumigatus Strains with TR34/L98H and G448S Cyp51A Mutations

Teresa Peláez

Journal of Fungi, 2021

View PDFchevron_right

Azole-resistant Aspergillus fumigatus in the environment: Identifying key reservoirs and hotspots of antifungal resistance

luisa londoño

PLOS Pathogens, 2021

View PDFchevron_right

Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon?

Saad Taj-Aldeen

Frontiers in Microbiology, 2018

View PDFchevron_right

Epidemiological Cutoffs and Cross-Resistance to Azole Drugs in Aspergillus fumigatus

Emilia Mellado

Antimicrobial Agents and Chemotherapy, 2008

View PDFchevron_right

Non-cyp51A Azole-Resistant Aspergillus fumigatus Isolates with Mutation in HMG-CoA Reductase

Katsuhiko Kamei

Emerging infectious diseases, 2018

View PDFchevron_right